The Board of Directors of Pharmesis International Ltd. announced that Mr. Jiang Yun has resigned as Executive Director and Chief Executive Officer, with effect from 31 December 2017. Consequently, Mr. Jiang also ceased as a member of Nominating Committee of the company. Mr. Qi Jie has been appointed as an Executive Director and Chief Operating Officer of the company with effect from 31 December 2017.
Mr. Wu Xuedan has been appointed as the Chief Executive Officer of the company and a member of Nominating Committee with effect from 31 December 2017. Consequent to the aforesaid changes, the composition of the Board and its Committees comprise the following members:- Board of Directors: Mr. Wu Xuedan Chief Executive Officer and Executive Director; Mr. Qi Jie Executive Director and Chief Operating Officer; Mr. Chew Heng Ching Independent Non-Executive Chairman; Mr. Chew Thiam Keng Independent Non-Executive Director; and Ms Chung Chia-Jung Non-Independent Non-Executive Director. Audit Committee: Mr. Chew Heng Ching Chairman; Mr. Chew Thiam Keng Member; and Ms. Chung Chia-Jung Member.
Nominating Committee: Mr. Chew Heng Ching Chairman; Mr. Chew Thiam Keng Member; and Mr. Wu Xuedan Member. Remuneration Committee: Mr. Chew Thiam Keng Chairman and Mr. Chew Heng Ching Member.